Shiga toxin-producing Escherichia coli haemolytic uraemic syndrome (STEC-HUS): diagnosis, surveillance and public-health management in England

Evaluation of chromogenic selective agar (CHROMagar STEC) for the direct detection of Shiga toxin-producing Escherichia coli from faecal specimens

(2020) Claire Jenkins et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Antimicrobial resistance in Shiga toxin-producing Escherichia coli other than serotype O157 : H7 in England, 2014–2016

(2020) Amy Gentle et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Recurrent seasonal outbreak of an emerging serotype of Shiga toxin-producing Escherichia coli (STEC O55:H7 Stx2a) in the south west of England, July 2014 to September 2015

(2017) Noëleen McFarland et al.   Eurosurveillance

Use of the EntericBio Gastro Panel II in a diagnostic microbiology laboratory: challenges and opportunities

(2017) Gary McAuliffe et al.   PATHOLOGY

High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine

(2017) Lucy A. McNamara et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

The epidemiology, microbiology and clinical impact of Shiga toxin-producing Escherichia coli in England, 2009–2012

(2015) L. BYRNE et al.   EPIDEMIOLOGY AND INFECTION

Early Volume Expansion and Outcomes of Hemolytic Uremic Syndrome

(2015) Gianluigi Ardissino et al.   PEDIATRICS

Epidemiology and microbiology of Shiga toxin-producing Escherichia coli other than serogroup O157 in England, 2009-2013

(2014) L. Byrne et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Infections in Pediatric Postdiarrheal Hemolytic Uremic Syndrome

(2012) Rajal K. Mody et al.   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Need for Long-term Follow-up in Enterohemorrhagic Escherichia coli–Associated Hemolytic Uremic Syndrome Due to Late-Emerging Sequelae

(2012) Alejandra Rosales et al.   CLINICAL INFECTIOUS DISEASES

Assessment of a real-time PCR for the detection and characterization of verocytotoxigenic Escherichia coli

(2012) C. Jenkins et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Eculizumab for Congenital Atypical Hemolytic–Uremic Syndrome

(2009) Ralph A. Gruppo et al.   NEW ENGLAND JOURNAL OF MEDICINE